Mar 30, 2019 - The FDA approves Merck KGaA (OTCPK:MKGAY) unit EMD Serono's Mavenclad (cladribine) tablets for the treatment of relapsing forms of multiple sclerosis (MS).Because of its safety profile, the dr
Mar 27, 2019 - Novartis (NVS) obtains FDA approval for Mayzent for the treatment of relapsing forms of MS.
Mar 26, 2019 - Celgene (CELG) progresses with the development of its MS candidate, as it submits an application for the same to the FDA.
Mar 25, 2019 - Celgene (NASDAQ:CELG) has filed a marketing application with the FDA seeking approval for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (MS).It filed an appli
Mar 21, 2019 - Williams (WMB) creates a $3.8-billion partnership with Canada Pension Plan Investment Board in the western Marcellus and Utica basins.
Mar 21, 2019 - Wall Street was mostly lower on Wednesday following decline in bank stocks after the Fed decided not to hike rate in 2019.
Mar 20, 2019 - This group of high-flying tech stocks has crushed the market in recent years. Will the good times continue?
Mar 13, 2019 -
Ozanimod, a drug for multiple sclerosis originating at Scripps Research, has been submitted for European approval by Celgene.
A U.S. Food and Drug Administration marketing application is also on track for filing by the end of March, the New Jersey-based drug company said Monday. The FDA rejected...
Mar 13, 2019 - Top Analyst Reports for Procter & Gamble, Netflix & Costco
Mar 12, 2019 - Celgene (CELG) submits application for MS drug, ozanimod to the European Medicines Agency.